Sonavex is a developer of an imaging technology designed to visualize and quantify critical data to detect anastomotic blood clots.
Sonavex has raised $3.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2026.
Sonavex's investors include TEDCO, Gaingels, Fusion Fund, National Science Foundation, Partners Capital.
Sonavex is headquartered in Baltimore, United States.
Sonavex is a developer of an imaging technology designed to visualize and quantify critical data to detect anastomotic blood clots.
Sonavex is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sonavex — Funding & Investors." VCBacked, July 28, 2026, https://www.vcbacked.co/company/sonavex. Accessed September 2, 2026.
VCBacked. (2026). Sonavex — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/sonavex
{{cite web |title=Sonavex — Funding & Investors |url=https://www.vcbacked.co/company/sonavex |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated